Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) reported that group therapy sessions may help patients cope with mesothelioma. Their two-part pilot study, which began recruitment in May 2011, is examining the emotional burden of the cancer and offers discussion groups as a source of...
Researchers at Memorial Sloan-Kettering Cancer Center reported that a new behavioral tapering intervention combined with cessation counseling and pharmacotherapy did not affect short- and long-term abstinence rates compared to cessation counseling and pharmacotherapy alone among smokers newly...
Researchers at City of Hope National Medical Center in Duarte, California, have been studying the effects of breast cancer on young women, particularly ethnic minorities and lower socioeconomic populations. They have found that young women are increasingly being diagnosed with breast cancer, yet...
This poster by Ms. Zadeh and colleagues was one of two tied for the Best Program award, presented by the APOS Scientific Program Committee at the Annual Meeting. The two award-winning posters were: Helping Providers to Help Adolescents and Young Adults be Involved in End-of-life Care: The...
Enabling adolescent and young adult (AYA) patients to become involved in advance care planning can help parents and health-care agents make informed decisions, alleviate distress, and possibly improve the patients’ quality of life, according to researchers at the National Cancer Institute’s...
Researchers at the University of Denver and Exempla Healthcare found that multiple distress screenings per patient over the course of cancer treatment informs health-care providers about emotional distress patterns and supportive needs over time. The information gathered allows providers to improve ...
The U.S. Food and Drug Administration has approved updated labeling for the reformulated painkiller OxyContin (controlled-release oxycodone hydrochloride). The new labeling will indicate that the drug has physical and chemical properties that make injection or snorting challenging. This new measure ...
In a study testing the effectiveness of three strategies to improve oral chemotherapy adherence, tailored coaching was beneficial for some patients, reducing barriers to adherence, reported Susan M. Schneider, PhD, RN, AOCN, ACNS-BC, FAAN, Associate Professor and Director of Oncology Nursing...
As of the ONS Annual Congress, three patients at Memorial Sloan-Kettering Cancer Center had been successfully treated in the outpatient setting with genetically modified T cell therapy, without major events or readmissions to the hospital, reported study author Cheryl Caravano, RN. Ms. Caravano...
Quality nursing and ongoing education are critical for success in using gene-modified T-cell therapy for patients with chronic lymphocytic leukemia (CLL), said Cheryl Caravano, RN, at the recent Annual Congress of the Oncology Nursing Society. Ms. Caravano is a clinical nurse IV at Memorial...
The annual memorial lecture is named for a remarkable patient with cancer who was the “model of survivorship,” sharing her story and helping others cope with the disease. The talk always focuses on a psychosocial aspect of cancer. Since its inception, over 125,000 nurses have attended Mara Mogensen ...
The Mara Mogensen Flagherty Lecture at this year’s 38th Annual Congress of the Oncology Nursing Society in Washington, DC, focused on the importance of listening to and acknowledging the individual stories of patients with cancer and survivors. Once they are adept at listening, clinicians need to...
The U.S. Food and Drug Administration has approved updated labeling for the reformulated painkiller OxyContin (controlled-release oxycodone hydrochloride). The new labeling will indicate that the drug has physical and chemical properties that make injection or snorting challenging. This new measure ...